Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 2Phase 1/2 2Phase 1 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Plasma cell 1

Conditions

Leukemia, Myeloid, Acute 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Myelodysplastic Syndromes 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Graft vs Host Disease 4Myeloproliferative Disorders 3Myasthenia Gravis 3Lymphoma, Non-Hodgkin 3Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Biphenotypic, Acute 2Hodgkin Disease 2Anemia, Refractory, with Excess of Blasts 2Skin Neoplasms 1Primary Myelofibrosis 1Neoplasms, Plasma Cell 1Myeloproliferative Syndrome, Transient 1Multiple Myeloma 1Leukemia 1Congenital Abnormalities 1Chromosome 5q Deletion Syndrome 1Carcinoma, Squamous Cell 1Carcinoma, Hepatocellular 1

Interventions

Methotrexate 7Cyclophosphamide 7Methylprednisolone 6merphos 5Cytarabine 5Asparaginase 5pegaspargase 4Vincristine 4Specimen Handling 4Mercaptopurine 4Leucovorin 4Dexamethasone 4Daunorubicin 4dexamethasone acetate 3dexamethasone 21-phosphate 3calaspargase pegol 3azathiopurine 3auricularum 3Thioguanine 3Prednisolone 3Hydrocortisone 3Etoposide 3Doxorubicin 3Calcium Dobesilate 3Antilymphocyte Serum 3prednylidene 2liposomal amphotericin B 2exifone 2deltacortene 2blinatumomab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Leukemia, Biphenotypic, Acute × Tacrolimus × Clear all
NCT05457556 2025-12-22

Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome

Children's Oncology Group

Phase 3 Active not recruiting
435 enrolled
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01951885 2023-09-11

Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention

Case Comprehensive Cancer Center

Phase 3 Completed
101 enrolled 28 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡